Phase II trial of imatinib mesylate in patients with metastatic melanoma von Kim, K B, Eton, O, Davis, D W, Frazier, M L, McConkey, D J, Diwan, A H, Papadopoulos, N E, Bedikian, A Y, Camacho, L H, Ross, M I, Cormier, J N, Gershenwald, J E, Lee, J E, Mansfield, P F, Billings, L A, Ng, C S, Charnsangavej, C, Bar-Eli, M, Johnson, M M, Murgo, A J, Prieto, V G

Volltext

Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study von Villalona-Calero, M.A., Otterson, G.A., Wientjes, M.G., Weber, F., Bekaii-Saab, T., Young, D., Murgo, A.J., Jensen, R., Yeh, T.-K., Wei, Y., Zhang, Y., Eng, C., Grever, M., Au, J. L.-S.

Volltext

Internalized Heterosexism and Substance Use: A Meta-Analysis von Huynh, Kiet D., Murgo, Michael A. J., Lee, Debbiesiu L.

Volltext

DNA Methylation: Its Role in Cancer Development and Therapy von Kurkjian, C., MD, Kummar, S., MD, Murgo, A.J., MD, MS

Volltext

Chemotherapy for breast cancer decreases plasma protein C and protein S von J S Rogers, 2nd, A J Murgo, J A Fontana, P C Raich

Volltext

Inhibition of B16-BL6 Melanoma Growth in Mice by Methionine-Enkephalin von Murgo, A J

Volltext

Clinical Trials of Arsenic Trioxide in Hematologic and Solid Tumors: Overview of the National Cancer Institute Cooperative Research and Development Studies von Murgo, Anthony J.

Volltext

Modulation of murine melanoma growth by naloxone von Murgo, A.J.

Volltext

Acute lymphoblastic leukemia with chromosomal 5;14 translocation and hypereosinophilia: case report and literature review von Hogan, T F, Koss, W, Murgo, A J, Amato, R S, Fontana, J A, VanScoy, F L

Volltext

Clinical trials referral resource. Clinical trials with arsenic trioxide von Murgo, A J, McBee, W L, Cheson, B D

Volltext

Innovative Approaches to the Clinical Development of DNA Methylation Inhibitors as Epigenetic Remodeling Drugs von Murgo, Anthony J.

Volltext

Renal failure and hemolytic anemia associated with mitomycin C. A case report von Price, Todd M., Murgo, Anthony J., Keveney, John J., Miller‐Hardy, Diane, Kasprisin, Duke O.

Volltext

Phase I Clinical and Pharmacokinetic Study of Flavopiridol Administered as a Daily 1-Hour Infusion in Patients With Advanced Neoplasms von TAN, Antoinette R, HEADLEE, Donna, SENDEROWICZ, Adrian M, MESSMANN, Richard, SAUSVILLE, Edward A, ARBUCK, Susan G, MURGO, Anthony J, MELILLO, Giovanni, SUOPING ZHAI, FIGG, William D, SWAIN, Sandra M

Volltext

Phase 0 Clinical Trials in Cancer Drug Development: From FDA Guidance to Clinical Practice von Kinders, Robert, Parchment, Ralph E, Ji, Jay, Kummar, Shivaani, Murgo, Anthony J, Gutierrez, Martin, Collins, Jerry, Rubinstein, Larry, Pickeral, Oxana, Steinberg, Seth M, Yang, Sherry, Hollingshead, Melinda, Chen, Alice, Helman, Lee, Wiltrout, Robert, Simpson, Mel, Tomaszewski, Joseph E, Doroshow, James H

Volltext

Methionine Enkephalin: A New Cytokine—Human Studies von Plotnikoff, Nicholas P., Faith, Robert E., Murgo, Anthony J., Herberman, Ronald B., Good, Robert A.

Volltext

Phase I study of vandetanib (V) and bevacizumab (B) combination therapy evaluating the VEGF and EGF signal transduction pathways in adults with solid tumors and NHL von Gutierrez, M., Murgo, A. J., Allen, D., Turkbey, I., Gardner, E. R., Trepel, J., Chen, H., Giaccone, G., Doroshow, J. H., Kummar, S.

Volltext

Normotensive pheochromocytoma von Murgo, A J

Volltext

Hydroxyurea and Sickle Cell Crisis von Ho, Peter T.C, Murgo, Anthony J, Silver, Richard T, Charache, Samuel, Dover, George J, Moore, Richard D, Terrin, Michael L

Volltext

Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin von Murgo, A J

Volltext

A phase II study of multikinase inhibitor sorafenib in patients with relapsed non-small cell lung cancer (NSCLC) von Gutierrez, M., Kummar, S., Allen, D., Turkbey, B., Choyke, P., Wright, J. J., Kurkjian, C., Giaccone, G., Doroshow, J. H., Murgo, A. J.

Volltext